Searchable abstracts of presentations at key conferences in endocrinology

ea0032p216 | Clinical case reports – Pituitary/Adrenal | ECE2013

Long-term treatment with octreotide in a patient with malignant pheochromocytoma: impact on survival and time to tumor progression

Gruszka Anna , Zieleniewski Wojciech , Kotecka-Blicharz Agnieszka , Jarzab Barbara , Kunert-Radek Jolanta

Introduction: Pheochromocytomas are rare neuroendocrine tumors arising from chromaffin cells of the adrenal medulla. Approximately 10% of all pheochromocytomas are malignant. There is no effective therapy for malignant pheochromocytoma (MAL-PHEO) and the overall prognosis is poor.Case report: We report 22-year survival with MAL-PHEO in a patient treated with several surgeries, 131I-metaiodobenzylguanidine and, subsequently, with long-acting fo...